The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announced new funding opportunities for researchers as part of its mission to accelerate the development of new and improved treatments for people with Parkinson’s disease (PD).
Interested members of the research community can apply to programs in several of the Foundation’s priority areas, including: defining PD and its progression, reducing the unmet symptoms of PD and the side effects of existing treatments, and altering the progression of the disease. In addition, MJFF is announcing the availability of critical research tools and models to the research and drug development community at large. As of today, researchers can apply to one of eight different programs.
Researchers seeking more information on current funding programs should visit the Priority Areas section of our website.
To find out more about how to take advantage of MJFF-supported pre-clinical and clinical biospecimens and data collection, visit the Resources Access Program.
For more information on open pipeline programs that seek novel investigator-initiated research and therapeutic development in any area relevant to PD, visit the Pipeline Programs pages.
Investigators should carefully review the various program details and deadlines to ensure they meet program requirements. As always, stay tuned for additional future funding opportunities by visiting www.michaeljfox.org.